Untitled
LIAISON® XS | DiaSorin
DiaSorin Molecular Gets More BARDA Funding to Submit Covid-19 Kits for FDA Clearance | Clinical Lab Products
Investors | DiaSorin
Comunicato Stampa
DiaSorin prosegue il buy-back
Untitled
DiaSorin - The Diagnostic Specialist
DiaSorin - The Diagnostic Specialist
GpèfpèfpfggfldSemestrale 2011
DIASORIN S.P.A. : DIA Stock Price | IT0003492391 | MarketScreener
Senza titolo
Diasorn Sole 18_7_07.indd
Results | DiaSorin
1 DiaSorin S.p.A. Autorizzazione all'acquisto e disposizione di azioni proprie, ai sensi del combinato disposto degli artt. 2357
ANNUAL FINANCIAL REPORT
LIAISON® XS | DiaSorin
Notice pursuant to article 143-quater, paragraph 5, of Consob Regulation no. 11971/99 Saluggia, July 28th, 2016 - List of Shar
DiaSorin concludes acquisition of Luminex for $1.8bn
